MedTrace Logo

Chronic Low Back Pain Research Project

NCT00108550 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2014-02-10

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether gabapentin is efficacious as an analgesic for chronic low back pain.

Conditions

  • Chronic Low Back Pain

Interventions

DRUG

gabapentin

Gabapentin 300m on Day 1, with daily or weekly increase to 3600 mg (maximum) by mouth by Week 5 of the 12-week trial

DRUG

Inert placebo

Inactive placebo capsule, one capsule on Day 1 with daily or weekly increase to 9 capsules daily by Week 5 of the 12-week trial

Sponsors & Collaborators

Principal Investigators

  • Joseph H. Atkinson, MD · VA San Diego Healthcare System, San Diego

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-10-31
Primary Completion
2009-07-31
Completion
2009-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00108550 on ClinicalTrials.gov